يعرض 1 - 10 نتائج من 212 نتيجة بحث عن '"Zalupski, M."', وقت الاستعلام: 1.10s تنقيح النتائج
  1. 1
    دورية أكاديمية
    A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma

    المؤلفون: Enzler, T., Nguyen, A., Misleh, J., Cline, V.J., Johns, M., Shumway, N., Paulson, S., Siegel, R., Larson, T., Messersmith, W., Richards, D., Chaves, J., Pierce, E., Zalupski, M., Sahai, V., Orr, D., Ruste, S.A., Haun, A., Kawabe, T.

    المصدر: In European Journal of Cancer April 2024 201

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA

    المؤلفون: Martin, L.K., Li, X., Kleiber, B., Ellison, E.C., Bloomston, M., Zalupski, M., Bekaii-Saab, T.S. *

    المصدر: In Annals of Oncology November 2012 23(11):2812-2820

    أضف إلى المفضلة
  3. 3
    كتاب إلكتروني
    Californium-252 in the Treatment of Soft Tissue Sarcoma

    المؤلفون: Fontanesi, J.Aff2, Zalupski, M.Aff2, Chuba, P.Aff2, Wierzbicki, J. G.Aff2, Rivard, M. J.Aff2, Ryan, J.Aff2

    المساهمون: Wierzbicki, Jacek G., editorAff1

    المصدر: Californium-252 Isotope for 21st Century Radiotherapy. 29:203-207

    Full Text Finder
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

    المؤلفون: El-Rayes, B.F. *, Zalupski, M., Bekai-Saab, T., Heilbrun, L.K., Hammad, N., Patel, B., Urba, S., Shields, A.F., Vaishampayan, U., Dawson, S., Almhanna, K., Smith, D., Philip, P.A.

    المصدر: In Annals of Oncology October 2010 21(10):1999-2004

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    1625P Multicenter, randomized, parallel group, phase II study to establish the efficacy and safety of CBP501, cisplatin, and nivolumab for ≥ third-line treatment of patients with exocrine pancreatic cancer and WBC

    المؤلفون: Enzler, T., Nguyen, A., Misleh, J., Cline, V.J., Johns, M.E., Shumway, N., Paulson, A.S., Siegel, R., Larson, T., Messersmith, W., Richards, D., Chaves, J., Pierce, E., Zalupski, M., Sahai, V., Orr, D., Kawabe, T., Ruste, S.A., Haun, A.

    المصدر: In Annals of Oncology October 2023 34 Supplement 2:S900-S900

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers

    المؤلفون: Ciuleanu, T., Diculescu, M., Hoepffner, N. M., Trojan, J., Sailer, V., Zalupski, M., Herrmann, T., Roth, A., Chick, J., Brock, K., Albert, D., Philip, P. A.

    المصدر: Investigational New Drugs: The Journal of New Anticancer Agents. August 2007 25(4):385-390

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    A Phase I Clinical Trial of Spicamycin Derivative KRN5500 (NSC 650426) Using a Phase I Accelerated Titration “2B” Design

    المؤلفون: Gadgeel, S.M., Boinpally, R.R., Heilbrun, L.K., Wozniak, A., Jain, V., Redman, B., Zalupski, M., Wiegand, R., Parchment, R., LoRusso, P.M.

    المصدر: Investigational New Drugs: An Interdisciplinary Journal for Clinicians and Scientists. February 2003 21(1):63-74

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    A phase II study of carboplatin and paclitaxel in esophageal cancer

    المؤلفون: El-Rayes, B.F., Shields, A., Zalupski, M., Heilbrun, L.K., Jain, V., Terry, D., Ferris, A., Philip, P.A. *

    المصدر: In Annals of Oncology June 2004 15(6):960-965

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    P-176 A multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin with or without CPI-613 as first-line therapy for patients with advanced unresectable biliary tract cancer (BilT-04)

    المؤلفون: Sahai, V., Chang, A., Crysler, O., Zhen, D., Luther, S., Zalupski, M.

    المصدر: In Annals of Oncology July 2021 32 Supplement 3:S160-S160

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    789TiP - HALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA)

    المؤلفون: Van Cutsem, E., Corrie, P.G., Ducreux, M.P., Sigal, D., Sahai, V., Oh, D.-Y., Bullock, A., Bang, Y.-J., Baron, A.D., Hendifar, A., Li, C.-P., Philip, P., Reni, M., Zalupski, M., Zheng, L., Berman, C., Chondros, D., Tempero, M.A.

    المصدر: In Annals of Oncology October 2018 29 Supplement 8

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء